Descrição

Inflammatory marker expression in vascular tissue from MTHFR-deficient models treated with SIRT1 activators. Reductions in inflammatory mediators suggest an anti-inflammatory mechanism underlying the vascular protective effects of SIRT1 activation.

Figure 6

Chart

Source Paper

SIRT1 pharmacological activation rescues vascular dysfunction and prevents thrombosis in MTHFR deficiency.

Cellular and molecular life sciences : CMLS (2022)

PMID: 35821533

DOI: 10.1007/s00018-022-04429-5

Cite This Figure

![Figure 6: Inflammatory marker expression in vascular tissue from MTHFR-deficient models treated with SIRT1 activators. Reductions in inflammatory mediators suggest an anti-inflammatory mechanism underlying the vascular protective effects of SIRT1 activation.]()

> Source: Albino Carrizzo et al. "SIRT1 pharmacological activation rescues vascular dysfunction and prevents throm." *Cellular and molecular life sciences : CMLS*, 2022. PMID: [35821533](https://pubmed.ncbi.nlm.nih.gov/35821533/)

<figure>
  <img src="" alt="Inflammatory marker expression in vascular tissue from MTHFR-deficient models treated with SIRT1 activators. Reductions in inflammatory mediators suggest an anti-inflammatory mechanism underlying the vascular protective effects of SIRT1 activation." />
  <figcaption>Figure 6. Inflammatory marker expression in vascular tissue from MTHFR-deficient models treated with SIRT1 activators. Reductions in inflammatory mediators suggest an anti-inflammatory mechanism underlying the vascular protective effects of SIRT1 activation.<br>  Source: Albino Carrizzo et al. "SIRT1 pharmacological activation rescues vascular dysfunction and prevents throm." <em>Cellular and molecular life sciences : CMLS</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35821533/">35821533</a></figcaption>
</figure>

Evidências Relacionadas

Resveratrol para Cerebrovascular Health

Nota C · 8 estudos